AbbVie's Upadacitinib Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis Biotech Investing
AbbVie's RINVOQ® Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Provides Update on Phase 2 Study of Deucravacitinib in Patients With Moderate to Severe Ulcerative Colitis Biotech Investing
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases Biotech Investing
October is Breast Cancer Awareness Month - BriaCell is Advancing the Fight with its Immunotherapy Biotech Investing
BioHarvest Sciences Inc. Reports Strong Q3 2021 Results on all of the Company's Activities Biotech Investing
